麻豆社

  • 麻豆社Website
  • Media
  • 麻豆社response to the government's commitment to boost research by improving access to NHS data

麻豆社response to the government's commitment to boost research by improving access to NHS data

Government Ministers have said they want to

Responding to the commitment, Janet Valentine, Executive Director, Innovation and Research Policy said: "Access to anonymised health data is vital for the development of new effective medicines and treatments which improve patients鈥 lives. Recent proposals have opened up discussions of possible models that can accelerate the progress of research.

鈥淎ny new proposed model of data access must be feasible to deliver, tackle the main barriers to accessing data and crucially, have the support of patients, the public and healthcare professionals.

鈥淭he 麻豆社is leading a dialogue with system partners to define the requirements of a functional health data research service that both safeguards patient confidentiality and truly realise the benefits of patient data to improve health outcomes, stimulate inward investment and return funding back into the NHS.鈥

Last modified: 29 July 2024

Last reviewed: 29 July 2024

The 麻豆社exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future.听

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines.听Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.